(AOF) – Genomic Vision announces that at its request reported on November 3, the Nanterre Commercial Court decided on November 15, 2023 the opening of a judicial recovery procedure. The operation of the company continues during the observation period, in accordance with legal provisions, and the suspension of the trading of shares, effective since November 6, 2023, remains maintained.
© 2023 Agence Option Finance (AOF) – All reproduction rights reserved by AOF. AOF collects its data from the sources it considers the safest. However, the reader remains solely responsible for their interpretation and use of the information made available to them. The reader must therefore hold AOF and its contributors harmless from any claim resulting from this use. Agence Option Finance (AOF) is a brand of the Option Finance group
Did you like this article ? Share it with your friends using the buttons below.
